Global spending on drugs may hit $1.1 trillion by 2024, but the rate of growth is forecast to slow. (STAT Plus)

More reads

• Regeneron says potential Covid-19 drugs could start human tests this summer. (STAT)
• Generic ‘identity’ gets lost when companies juggle both generic and brand drugs. (STAT)
• Biogen staffer fled to China in search of emergency Covid-19 testing, care — and now faces criminal charges. (Endpoints)
• Global spending on drugs may hit $1.1 trillion by 2024, but the rate of growth is forecast to slow. (STAT Plus)